Tirzepatide may be considered after clinical intake and review by a U.S.-licensed clinician at $345/mo if prescribed. Completing intake does not guarantee a prescription. If appropriate, care is individualized and fulfilled through a licensed pharmacy partner.
Key Benefits
Licensed clinician review before any prescription
Dual-pathway GLP-1 + GIP option when clinically appropriate
Provider oversight if treatment continues
Discreet fulfillment through pharmacy partners
Start with a clinical review
Complete clinical intake so a licensed provider can review your case — $345/mo if prescribed. Intake alone does not guarantee a prescription.
✓ U.S. licensed clinicians✓ Discreet fulfillment when prescribed✓ $345/mo if prescribed
